Clinical Trial Update: Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous immune globulin for age-related macular degeneration; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Immune Globulin Intravenous (Human) (intravenous immunoglobulin)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2016-03-21